Stanozolol Depot

ACTIVE INGREDIENT

Each mL contains:

• Stanozolol 50 mg

DESCRIPTION

Stanozolol Depot 50 mg is an injectable anabolic steroid containing stanozolol, a synthetic derivative of dihydrotestosterone (DHT). It is formulated as a water-based suspension, delivering stanozolol in a crystalline form. Known for its strong anabolic effects and mild androgenic properties, it promotes lean muscle growth, enhances protein synthesis, and reduces water retention, making it a popular choice in bodybuilding and athletics.

PHARMACOLOGICAL PROPERTIES

Mechanism of Action: Stanozolol binds to androgen receptors, stimulating protein synthesis, enhancing nitrogen retention, and promoting muscle growth. Its anabolic properties help preserve lean muscle mass and reduce fat, making it effective in catabolic states.

Pharmacokinetics:

• Absorption: Stanozolol depot formulation provides a sustained release after intramuscular injection.
• Distribution: It is distributed widely in tissues, with a high binding affinity for plasma proteins.
• Metabolism: Primarily metabolized in the liver.
• Excretion: Excreted mainly through urine as metabolites.

INDICATIONS

Stanozolol Depot 50 mg is indicated for:

Hereditary angioedema: To reduce the severity and frequency of attacks.

Adjunct therapy in anemia: To stimulate red blood cell production in some cases of anemia.

Treatment of muscle-wasting conditions: To preserve muscle mass in patients with chronic wasting conditions.

Performance enhancement: Used in sports and bodybuilding to increase strength, muscle mass, and performance while minimizing fluid retention.

DOSAGE AND ADMINISTRATION

Dosage:

• Medical Use (Hereditary Angioedema): 2 mg/kg administered intramuscularly once every 2–4 weeks or as prescribed by the healthcare provider.
• Anabolic/Bodybuilding Use: Common doses range from 50 mg every other day to 100 mg every 2–3 days. Dosage depends on the user’s experience, goals, and tolerance levels.

Administration:

• Administer via deep intramuscular injection. Rotate injection sites regularly to avoid localized irritation or pain. Shake the vial well before administration to ensure uniform suspension.

CONTRAINDICATIONS

• Hypersensitivity to stanozolol or any component of the formulation.

• Pregnancy and lactation (Pregnancy Category X).

• Active breast cancer in females or suspected prostate cancer in males.

• Severe cardiovascular, renal, or hepatic disease.

• Hypercalcemia (high blood calcium levels).

WARNINGS AND PRECAUTIONS

1. Hepatic Toxicity: Stanozolol is known for its potential to cause liver toxicity, particularly in high doses or with long-term use. Regular liver function tests are recommended.

2. Cardiovascular Risks: Prolonged use of anabolic steroids may increase the risk of cardiovascular issues such as atherosclerosis, hypertension, myocardial infarction, and stroke. Patients should be monitored for lipid profile changes and cardiovascular health.

3. Androgenic Effects: Stanozolol, while primarily anabolic, may cause androgenic effects like acne, hair loss, and increased body hair. Women may experience virilization (deepening of the voice, clitoral enlargement, menstrual irregularities).

4. Lipid Profile Alterations: Stanozolol can negatively affect cholesterol levels, decreasing HDL (good cholesterol) and increasing LDL (bad cholesterol). Regular lipid monitoring is advised.

5. Tendon Weakness: Stanozolol use has been associated with an increased risk of tendon damage. Caution is recommended during intense physical activity.

ADVERSE REACTIONS

Common adverse reactions:

• Dermatological effects: Acne, oily skin, hair loss (androgenic alopecia).
• Endocrine effects: Suppression of natural testosterone production, testicular atrophy.
• Musculoskeletal: Muscle cramps, tendon pain.
• Liver: Elevated liver enzymes, jaundice.

Serious adverse reactions:

• Hepatotoxicity: Liver damage, cholestatic hepatitis, hepatic tumors, and peliosis hepatis.
• Cardiovascular: Increased risk of blood clots, hypertension, and cardiovascular events.
• Endocrine: Gynecomastia (in males), virilization in women.
• Psychiatric effects: Aggression, mood swings, irritability, or depression.

INTERACTIONS

1. Anticoagulants: Stanozolol may enhance the effects of anticoagulants like warfarin, increasing the risk of bleeding. Close monitoring of INR is advised.

2. Insulin and Oral Antidiabetics: Anabolic steroids can affect blood sugar levels and may require adjustment of insulin or oral hypoglycemic medications.

3. Corticosteroids: Concurrent use with corticosteroids may exacerbate fluid retention and increase the risk of electrolyte imbalances.

USE IN SPECIFIC POPULATIONS

Pregnancy and Lactation: Stanozolol is contraindicated in pregnancy due to the risk of fetal harm (Pregnancy Category X). It should not be used during breastfeeding.

Pediatric Use: Caution should be exercised when administering stanozolol to pediatric patients, as it may cause premature closure of growth plates (epiphyseal closure) and stunt growth.

Geriatric Use: Geriatric patients may be more susceptible to the cardiovascular and hepatic effects of stanozolol. Monitoring is required during use in this population.

OVERDOSAGE

There is no specific antidote for stanozolol overdose. In the case of overdose, discontinue use and provide symptomatic treatment. Liver and cardiovascular function should be monitored closely.

STORAGE

Store below 25°C (77°F). Protect from light. Do not refrigerate or freeze. Keep out of reach of children.

PACKAGING

Stanozolol Depot 50 mg is supplied in 10 mL vials, each containing 50 mg of stanozolol in a water-based suspension.

MANUFACTURER

Oxydine Metabolics Switzerland

Oxydine.org
Hi@Oxydine.org